ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Epirubicin Hydrochloride Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-17L8956
Home | Market Reports
Global Epirubicin Hydrochloride Market Outlook 2022
BUY CHAPTERS

Global Epirubicin Hydrochloride Market Research Report 2026

Code: QYRE-Auto-17L8956
Report
2026-03-31
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva API
MicroBiopharm Japan
Synbias Pharma
Sterling Biotech
Zhejiang Hisun Pharma
Intas Pharma
Lunan Pharmaceutical Group
Pfizer Inc
Beijing Union Pharmaceutical Factory
Flavine
DZD Heze Pharma
Humble Healthcaare

Epirubicin Hydrochloride Market Size

The global Epirubicin Hydrochloride market was valued at US$ 235 million in 2025 and is anticipated to reach US$ 197 million by 2032, at a CAGR of -2.5% from 2026 to 2032.

Epirubicin Hydrochloride Market

Epirubicin Hydrochloride Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Epirubicin Hydrochloride competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.
Epirubicin hydrochloride is an anthracycline antitumor antibiotic developed by Pfizer for the treatment of breast cancer, lung cancer, and liver cancer. It was launched in Europe in 1984 and in the United States in 1999. It is widely used in the treatment of leukemia, lymphoma, and various solid tumors (including breast cancer, non-small cell tumors, cervical cancer, and head and neck cancer). Its mechanism of action is to directly embed between DNA nucleobase pairs, interfere with the transcription process, prevent the formation of mRNA, and thus inhibit the synthesis of DNA and RNA. In addition, epirubicin also has an inhibitory effect on topoisomerase II. It is a cell cycle non-specific drug that is effective against a variety of transplanted tumors. Compared with doxorubicin, it has equal or slightly higher efficacy, but is less toxic to the heart.
Global core Epirubicin Hydrochloride players include Synbias Pharma, Zhejiang Hisun Pharma and Pfizer etc. The top 3 companies hold a share about 60%. Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%. And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.
This report delivers a comprehensive overview of the global Epirubicin Hydrochloride market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Epirubicin Hydrochloride. The Epirubicin Hydrochloride market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Epirubicin Hydrochloride market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Epirubicin Hydrochloride manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Epirubicin Hydrochloride Market Report

Report Metric Details
Report Name Epirubicin Hydrochloride Market
Accounted market size in 2025 US$ 235 million
Forecasted market size in 2032 US$ 197 million
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 10mg/5ml
  • 50mg/25ml
  • Other
by Application
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API, Microbiopharm Japan, DZD Heze Pharma, Synbias Pharma, Intas Pharma, Humble Healthcaare, Lunan Pharmaceutical Group, Pfizer, Beijing Union Pharmaceutical Factory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Epirubicin Hydrochloride manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Epirubicin Hydrochloride sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the Epirubicin Hydrochloride Market size in 2032?

Ans: The Epirubicin Hydrochloride Market size in 2032 will be US$ 197 million.

What is the market share of major companies in Epirubicin Hydrochloride Market?

Ans: The top 3 companies hold a share about 60%.

What is the Epirubicin Hydrochloride Market share by region?

Ans: Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%.

What is the Epirubicin Hydrochloride Market share by type?

Ans: In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%.

What is the Epirubicin Hydrochloride Market share by application?

Ans: And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.

Who are the main players in the Epirubicin Hydrochloride Market report?

Ans: The main players in the Epirubicin Hydrochloride Market are Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API, Microbiopharm Japan, DZD Heze Pharma, Synbias Pharma, Intas Pharma, Humble Healthcaare, Lunan Pharmaceutical Group, Pfizer, Beijing Union Pharmaceutical Factory

What are the Application segmentation covered in the Epirubicin Hydrochloride Market report?

Ans: The Applications covered in the Epirubicin Hydrochloride Market report are Cancer, Others

What are the Type segmentation covered in the Epirubicin Hydrochloride Market report?

Ans: The Types covered in the Epirubicin Hydrochloride Market report are 10mg/5ml, 50mg/25ml, Other

1 Epirubicin Hydrochloride Market Overview
1.1 Product Definition
1.2 Epirubicin Hydrochloride by Type
1.2.1 Global Epirubicin Hydrochloride Market Value by Type: 2025 vs 2032
1.2.2 10mg/5ml
1.2.3 50mg/25ml
1.2.4 Other
1.3 Epirubicin Hydrochloride by Application
1.3.1 Global Epirubicin Hydrochloride Market Value by Application: 2025 vs 2032
1.3.2 Cancer
1.3.3 Others
1.4 Global Epirubicin Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Epirubicin Hydrochloride Revenue 2021–2032
1.4.2 Global Epirubicin Hydrochloride Sales 2021–2032
1.4.3 Global Epirubicin Hydrochloride Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Epirubicin Hydrochloride Market Competition by Manufacturers
2.1 Global Epirubicin Hydrochloride Sales Market Share by Manufacturers (2021–2026)
2.2 Global Epirubicin Hydrochloride Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Epirubicin Hydrochloride Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Epirubicin Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Epirubicin Hydrochloride, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Epirubicin Hydrochloride, Product Types and Applications
2.7 Global Key Manufacturers of Epirubicin Hydrochloride, Date of Entry into the Industry
2.8 Global Epirubicin Hydrochloride Market Competitive Situation and Trends
2.8.1 Global Epirubicin Hydrochloride Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Epirubicin Hydrochloride Players Market Share by Revenue
2.8.3 Global Epirubicin Hydrochloride Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Epirubicin Hydrochloride Market Scenario by Region
3.1 Global Epirubicin Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Epirubicin Hydrochloride Sales by Region: 2021–2032
3.2.1 Global Epirubicin Hydrochloride Sales by Region: 2021–2026
3.2.2 Global Epirubicin Hydrochloride Sales by Region: 2027–2032
3.3 Global Epirubicin Hydrochloride Revenue by Region: 2021–2032
3.3.1 Global Epirubicin Hydrochloride Revenue by Region: 2021–2026
3.3.2 Global Epirubicin Hydrochloride Revenue by Region: 2027–2032
3.4 North America Epirubicin Hydrochloride Market Facts & Figures by Country
3.4.1 North America Epirubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Epirubicin Hydrochloride Sales by Country (2021–2032)
3.4.3 North America Epirubicin Hydrochloride Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Epirubicin Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Epirubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Epirubicin Hydrochloride Sales by Country (2021–2032)
3.5.3 Europe Epirubicin Hydrochloride Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epirubicin Hydrochloride Market Facts & Figures by Region
3.6.1 Asia Pacific Epirubicin Hydrochloride Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Epirubicin Hydrochloride Sales by Region (2021–2032)
3.6.3 Asia Pacific Epirubicin Hydrochloride Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Epirubicin Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Epirubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Epirubicin Hydrochloride Sales by Country (2021–2032)
3.7.3 Latin America Epirubicin Hydrochloride Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epirubicin Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Epirubicin Hydrochloride Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Epirubicin Hydrochloride Sales by Country (2021–2032)
3.8.3 Middle East and Africa Epirubicin Hydrochloride Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Epirubicin Hydrochloride Sales by Type (2021–2032)
4.1.1 Global Epirubicin Hydrochloride Sales by Type (2021–2026)
4.1.2 Global Epirubicin Hydrochloride Sales by Type (2027–2032)
4.1.3 Global Epirubicin Hydrochloride Sales Market Share by Type (2021–2032)
4.2 Global Epirubicin Hydrochloride Revenue by Type (2021–2032)
4.2.1 Global Epirubicin Hydrochloride Revenue by Type (2021–2026)
4.2.2 Global Epirubicin Hydrochloride Revenue by Type (2027–2032)
4.2.3 Global Epirubicin Hydrochloride Revenue Market Share by Type (2021–2032)
4.3 Global Epirubicin Hydrochloride Price by Type (2021–2032)
5 Segment by Application
5.1 Global Epirubicin Hydrochloride Sales by Application (2021–2032)
5.1.1 Global Epirubicin Hydrochloride Sales by Application (2021–2026)
5.1.2 Global Epirubicin Hydrochloride Sales by Application (2027–2032)
5.1.3 Global Epirubicin Hydrochloride Sales Market Share by Application (2021–2032)
5.2 Global Epirubicin Hydrochloride Revenue by Application (2021–2032)
5.2.1 Global Epirubicin Hydrochloride Revenue by Application (2021–2026)
5.2.2 Global Epirubicin Hydrochloride Revenue by Application (2027–2032)
5.2.3 Global Epirubicin Hydrochloride Revenue Market Share by Application (2021–2032)
5.3 Global Epirubicin Hydrochloride Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sterling Biotech
6.1.1 Sterling Biotech Company Information
6.1.2 Sterling Biotech Description and Business Overview
6.1.3 Sterling Biotech Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sterling Biotech Epirubicin Hydrochloride Product Portfolio
6.1.5 Sterling Biotech Recent Developments/Updates
6.2 Zhejiang Hisun Pharma
6.2.1 Zhejiang Hisun Pharma Company Information
6.2.2 Zhejiang Hisun Pharma Description and Business Overview
6.2.3 Zhejiang Hisun Pharma Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Zhejiang Hisun Pharma Epirubicin Hydrochloride Product Portfolio
6.2.5 Zhejiang Hisun Pharma Recent Developments/Updates
6.3 Flavine
6.3.1 Flavine Company Information
6.3.2 Flavine Description and Business Overview
6.3.3 Flavine Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Flavine Epirubicin Hydrochloride Product Portfolio
6.3.5 Flavine Recent Developments/Updates
6.4 Teva API
6.4.1 Teva API Company Information
6.4.2 Teva API Description and Business Overview
6.4.3 Teva API Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva API Epirubicin Hydrochloride Product Portfolio
6.4.5 Teva API Recent Developments/Updates
6.5 Microbiopharm Japan
6.5.1 Microbiopharm Japan Company Information
6.5.2 Microbiopharm Japan Description and Business Overview
6.5.3 Microbiopharm Japan Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Microbiopharm Japan Epirubicin Hydrochloride Product Portfolio
6.5.5 Microbiopharm Japan Recent Developments/Updates
6.6 DZD Heze Pharma
6.6.1 DZD Heze Pharma Company Information
6.6.2 DZD Heze Pharma Description and Business Overview
6.6.3 DZD Heze Pharma Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 DZD Heze Pharma Epirubicin Hydrochloride Product Portfolio
6.6.5 DZD Heze Pharma Recent Developments/Updates
6.7 Synbias Pharma
6.7.1 Synbias Pharma Company Information
6.7.2 Synbias Pharma Description and Business Overview
6.7.3 Synbias Pharma Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Synbias Pharma Epirubicin Hydrochloride Product Portfolio
6.7.5 Synbias Pharma Recent Developments/Updates
6.8 Intas Pharma
6.8.1 Intas Pharma Company Information
6.8.2 Intas Pharma Description and Business Overview
6.8.3 Intas Pharma Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Intas Pharma Epirubicin Hydrochloride Product Portfolio
6.8.5 Intas Pharma Recent Developments/Updates
6.9 Humble Healthcaare
6.9.1 Humble Healthcaare Company Information
6.9.2 Humble Healthcaare Description and Business Overview
6.9.3 Humble Healthcaare Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Humble Healthcaare Epirubicin Hydrochloride Product Portfolio
6.9.5 Humble Healthcaare Recent Developments/Updates
6.10 Lunan Pharmaceutical Group
6.10.1 Lunan Pharmaceutical Group Company Information
6.10.2 Lunan Pharmaceutical Group Description and Business Overview
6.10.3 Lunan Pharmaceutical Group Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lunan Pharmaceutical Group Epirubicin Hydrochloride Product Portfolio
6.10.5 Lunan Pharmaceutical Group Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Pfizer Epirubicin Hydrochloride Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Beijing Union Pharmaceutical Factory
6.12.1 Beijing Union Pharmaceutical Factory Company Information
6.12.2 Beijing Union Pharmaceutical Factory Description and Business Overview
6.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product Portfolio
6.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epirubicin Hydrochloride Industry Chain Analysis
7.2 Epirubicin Hydrochloride Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epirubicin Hydrochloride Production Mode & Process Analysis
7.4 Epirubicin Hydrochloride Sales and Marketing
7.4.1 Epirubicin Hydrochloride Sales Channels
7.4.2 Epirubicin Hydrochloride Distributors
7.5 Epirubicin Hydrochloride Customer Analysis
8 Epirubicin Hydrochloride Market Dynamics
8.1 Epirubicin Hydrochloride Industry Trends
8.2 Epirubicin Hydrochloride Market Drivers
8.3 Epirubicin Hydrochloride Market Challenges
8.4 Epirubicin Hydrochloride Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva API
MicroBiopharm Japan
Synbias Pharma
Sterling Biotech
Zhejiang Hisun Pharma
Intas Pharma
Lunan Pharmaceutical Group
Pfizer Inc
Beijing Union Pharmaceutical Factory
Flavine
DZD Heze Pharma
Humble Healthcaare
List of Tables
 Table 1. Global Epirubicin Hydrochloride Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Epirubicin Hydrochloride Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Epirubicin Hydrochloride Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Epirubicin Hydrochloride Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Epirubicin Hydrochloride Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Epirubicin Hydrochloride Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Epirubicin Hydrochloride Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Epirubicin Hydrochloride Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Epirubicin Hydrochloride, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Epirubicin Hydrochloride, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Epirubicin Hydrochloride, Product Types and Applications
 Table 12. Global Key Manufacturers of Epirubicin Hydrochloride, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Epirubicin Hydrochloride Companies by Tier (Tier 1, Tier 2, Tier 3), based on Epirubicin Hydrochloride Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Epirubicin Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Epirubicin Hydrochloride Sales by Region (Kg), 2021–2026
 Table 18. Global Epirubicin Hydrochloride Sales Market Share by Region (2021–2026)
 Table 19. Global Epirubicin Hydrochloride Sales by Region (Kg), 2027–2032
 Table 20. Global Epirubicin Hydrochloride Sales Market Share by Region (2027–2032)
 Table 21. Global Epirubicin Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Epirubicin Hydrochloride Revenue Market Share by Region (2021–2026)
 Table 23. Global Epirubicin Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Epirubicin Hydrochloride Revenue Market Share by Region (2027–2032)
 Table 25. North America Epirubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Epirubicin Hydrochloride Sales by Country (Kg), 2021–2026
 Table 27. North America Epirubicin Hydrochloride Sales by Country (Kg), 2027–2032
 Table 28. North America Epirubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Epirubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Epirubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Epirubicin Hydrochloride Sales by Country (Kg), 2021–2026
 Table 32. Europe Epirubicin Hydrochloride Sales by Country (Kg), 2027–2032
 Table 33. Europe Epirubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Epirubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Epirubicin Hydrochloride Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Epirubicin Hydrochloride Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Epirubicin Hydrochloride Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Epirubicin Hydrochloride Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Epirubicin Hydrochloride Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Epirubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Epirubicin Hydrochloride Sales by Country (Kg), 2021–2026
 Table 42. Latin America Epirubicin Hydrochloride Sales by Country (Kg), 2027–2032
 Table 43. Latin America Epirubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Epirubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Epirubicin Hydrochloride Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Epirubicin Hydrochloride Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Epirubicin Hydrochloride Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Epirubicin Hydrochloride Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Epirubicin Hydrochloride Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Epirubicin Hydrochloride Sales (Kg) by Type (2021–2026)
 Table 51. Global Epirubicin Hydrochloride Sales (Kg) by Type (2027–2032)
 Table 52. Global Epirubicin Hydrochloride Sales Market Share by Type (2021–2026)
 Table 53. Global Epirubicin Hydrochloride Sales Market Share by Type (2027–2032)
 Table 54. Global Epirubicin Hydrochloride Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Epirubicin Hydrochloride Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Epirubicin Hydrochloride Revenue Market Share by Type (2021–2026)
 Table 57. Global Epirubicin Hydrochloride Revenue Market Share by Type (2027–2032)
 Table 58. Global Epirubicin Hydrochloride Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Epirubicin Hydrochloride Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Epirubicin Hydrochloride Sales (Kg) by Application (2021–2026)
 Table 61. Global Epirubicin Hydrochloride Sales (Kg) by Application (2027–2032)
 Table 62. Global Epirubicin Hydrochloride Sales Market Share by Application (2021–2026)
 Table 63. Global Epirubicin Hydrochloride Sales Market Share by Application (2027–2032)
 Table 64. Global Epirubicin Hydrochloride Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Epirubicin Hydrochloride Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Epirubicin Hydrochloride Revenue Market Share by Application (2021–2026)
 Table 67. Global Epirubicin Hydrochloride Revenue Market Share by Application (2027–2032)
 Table 68. Global Epirubicin Hydrochloride Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Epirubicin Hydrochloride Price (US$/Kg) by Application (2027–2032)
 Table 70. Sterling Biotech Company Information
 Table 71. Sterling Biotech Description and Business Overview
 Table 72. Sterling Biotech Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Sterling Biotech Epirubicin Hydrochloride Product
 Table 74. Sterling Biotech Recent Developments/Updates
 Table 75. Zhejiang Hisun Pharma Company Information
 Table 76. Zhejiang Hisun Pharma Description and Business Overview
 Table 77. Zhejiang Hisun Pharma Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. Zhejiang Hisun Pharma Epirubicin Hydrochloride Product
 Table 79. Zhejiang Hisun Pharma Recent Developments/Updates
 Table 80. Flavine Company Information
 Table 81. Flavine Description and Business Overview
 Table 82. Flavine Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Flavine Epirubicin Hydrochloride Product
 Table 84. Flavine Recent Developments/Updates
 Table 85. Teva API Company Information
 Table 86. Teva API Description and Business Overview
 Table 87. Teva API Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. Teva API Epirubicin Hydrochloride Product
 Table 89. Teva API Recent Developments/Updates
 Table 90. Microbiopharm Japan Company Information
 Table 91. Microbiopharm Japan Description and Business Overview
 Table 92. Microbiopharm Japan Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. Microbiopharm Japan Epirubicin Hydrochloride Product
 Table 94. Microbiopharm Japan Recent Developments/Updates
 Table 95. DZD Heze Pharma Company Information
 Table 96. DZD Heze Pharma Description and Business Overview
 Table 97. DZD Heze Pharma Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. DZD Heze Pharma Epirubicin Hydrochloride Product
 Table 99. DZD Heze Pharma Recent Developments/Updates
 Table 100. Synbias Pharma Company Information
 Table 101. Synbias Pharma Description and Business Overview
 Table 102. Synbias Pharma Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. Synbias Pharma Epirubicin Hydrochloride Product
 Table 104. Synbias Pharma Recent Developments/Updates
 Table 105. Intas Pharma Company Information
 Table 106. Intas Pharma Description and Business Overview
 Table 107. Intas Pharma Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 108. Intas Pharma Epirubicin Hydrochloride Product
 Table 109. Intas Pharma Recent Developments/Updates
 Table 110. Humble Healthcaare Company Information
 Table 111. Humble Healthcaare Description and Business Overview
 Table 112. Humble Healthcaare Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 113. Humble Healthcaare Epirubicin Hydrochloride Product
 Table 114. Humble Healthcaare Recent Developments/Updates
 Table 115. Lunan Pharmaceutical Group Company Information
 Table 116. Lunan Pharmaceutical Group Description and Business Overview
 Table 117. Lunan Pharmaceutical Group Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 118. Lunan Pharmaceutical Group Epirubicin Hydrochloride Product
 Table 119. Lunan Pharmaceutical Group Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 123. Pfizer Epirubicin Hydrochloride Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Beijing Union Pharmaceutical Factory Company Information
 Table 126. Beijing Union Pharmaceutical Factory Description and Business Overview
 Table 127. Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 128. Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product
 Table 129. Beijing Union Pharmaceutical Factory Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Epirubicin Hydrochloride Distributors List
 Table 133. Epirubicin Hydrochloride Customers List
 Table 134. Epirubicin Hydrochloride Market Trends
 Table 135. Epirubicin Hydrochloride Market Drivers
 Table 136. Epirubicin Hydrochloride Market Challenges
 Table 137. Epirubicin Hydrochloride Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Epirubicin Hydrochloride
 Figure 2. Global Epirubicin Hydrochloride Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Epirubicin Hydrochloride Market Share by Type: 2025 & 2032
 Figure 4. 10mg/5ml Product Picture
 Figure 5. 50mg/25ml Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Epirubicin Hydrochloride Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Epirubicin Hydrochloride Market Share by Application: 2025 & 2032
 Figure 9. Cancer
 Figure 10. Others
 Figure 11. Global Epirubicin Hydrochloride Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Epirubicin Hydrochloride Market Size (US$ Million), 2021–2032
 Figure 13. Global Epirubicin Hydrochloride Sales (Kg), 2021–2032
 Figure 14. Global Epirubicin Hydrochloride Average Price (US$/Kg), 2021–2032
 Figure 15. Epirubicin Hydrochloride Report Years Considered
 Figure 16. Epirubicin Hydrochloride Sales Share by Manufacturers in 2025
 Figure 17. Global Epirubicin Hydrochloride Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Epirubicin Hydrochloride Players: Market Share by Revenue in Epirubicin Hydrochloride in 2025
 Figure 19. Epirubicin Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Epirubicin Hydrochloride Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Epirubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 22. North America Epirubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 23. United States Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Epirubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 26. Europe Epirubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Epirubicin Hydrochloride Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Epirubicin Hydrochloride Revenue Market Share by Region (2021–2032)
 Figure 34. China Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Epirubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Epirubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Epirubicin Hydrochloride Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Epirubicin Hydrochloride Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Epirubicin Hydrochloride Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Epirubicin Hydrochloride by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Epirubicin Hydrochloride by Type (2021–2032)
 Figure 55. Global Epirubicin Hydrochloride Price (US$/Kg) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Epirubicin Hydrochloride by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Epirubicin Hydrochloride by Application (2021–2032)
 Figure 58. Global Epirubicin Hydrochloride Price (US$/Kg) by Application (2021–2032)
 Figure 59. Epirubicin Hydrochloride Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Epirubicin HCl Market Research Report 2025
Global Doxorubicin Hydrochloride Injection Market Research Report 2024
Global Epirubicin Hydrochloride API Market Research Report 2024
Global Doxorubicin Hydrochloride Market Research Report 2024
Global Epirubicin Hydrochloride Injection Market Research Report 2025
Global Idarubicin Hydrochloride for Injection Market Research Report 2024
Global Doxorubicin Hydrochloride API Market Research Report 2024
Anthracyclines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Daunorubicin Market Research Report 2024
Global Irinotecan Hydrochloride Injection Market Research Report 2025
Global Tetracycline Hydrochloride Market Insights Forecast to 2030
Global Doxorubicin Injection Market Research Report 2024
Global Pirarubicin Hydrochloride for Injection Market Research Report 2024
Global Pirarubicin Market Research Report 2024
Global Aclarubicin Hydrochlorid For Injection Market Research Report 2024
Global Idarubicin Hydrochloride Market Research Report 2025
Global Ecetinib Hydrochloride Market Research Report 2024
Global Daunorubicin Hydrochloride Injection Market Research Report 2025
Global Idarubicin Hydrochloride API Market Research Report 2024
Global Liposomal Daunorubicin and Cytarabine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions